Literature DB >> 13985738

The distribution of adenovirus antibodies in normal children.

C W POTTER, W I SHEDDEN.   

Abstract

Entities:  

Keywords:  ADENOVIRUS INFECTIONS; ANTIBODIES

Mesh:

Substances:

Year:  1963        PMID: 13985738      PMCID: PMC2134551          DOI: 10.1017/s0022172400020830

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


× No keyword cloud information.
  7 in total

1.  Studies of the significance of the recall phenomenon in the antibody response to adenovirus vaccine and infection.

Authors:  A PRINS
Journal:  J Immunol       Date:  1960-06       Impact factor: 5.422

2.  A guinea pig potency test for adenovirus vaccine.

Authors:  L N BINN; M R HILLEMAN
Journal:  J Immunol       Date:  1960-01       Impact factor: 5.422

3.  A study of illness in a group of Cleveland families. XV. Acquisition of type-specific adenovirus antibodies in the first five years of life; implications for the use of adenovirus vaccine.

Authors:  W S JORDAN; G F BADGER; J H DINGLE
Journal:  N Engl J Med       Date:  1958-05-22       Impact factor: 91.245

4.  Typing of adenoidal-pharyngeal-conjunctival (APC) viruses by complement-fixation.

Authors:  H G PEREIRA
Journal:  J Pathol Bacteriol       Date:  1956-07

5.  Acute infections of the respiratory tract and the adenoviruses.

Authors:  D BALDUCCI; D A TYRRELL; T E ZAIMAN
Journal:  Lancet       Date:  1956-12-29       Impact factor: 79.321

6.  Adenoidal-pharyngeal-conjunctival agents: a newly recognized group of common viruses of the respiratory system.

Authors:  R J HUEBNER; W P ROWE; T G WARD; R H PARROTT; J A BELL
Journal:  N Engl J Med       Date:  1954-12-30       Impact factor: 91.245

7.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  7 in total
  9 in total

1.  PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections.

Authors:  David Metzgar; Miguel Osuna; Samuel Yingst; Magda Rakha; Kenneth Earhart; Diaa Elyan; Hala Esmat; Magdi D Saad; Adriana Kajon; Jianguo Wu; Gregory C Gray; Margaret A K Ryan; Kevin L Russell
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Adenovirus microsatellite reveals dynamics of transmission during a recent epidemic of human adenovirus serotype 14 infection.

Authors:  Huo-Shu H Houng; Lisa Lott; Heping Gong; Robert A Kuschner; Julia A Lynch; David Metzgar
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

3.  [Latent adenovirus infections in children and adults (otorhinolaryngologic studies in the Rostock area].

Authors:  P Solisch; A Kewitsch; B Kretschmer
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1968

4.  [Epidemiological studies on adenovirus infections].

Authors:  H Lippelt; W Schulze
Journal:  Z Med Mikrobiol Immunol       Date:  1966

5.  Antibody levels in human sera to oncogenic adenoviruses (types 7, 12 and 18).

Authors:  C W Potter; G C Schild
Journal:  Arch Gesamte Virusforsch       Date:  1966

6.  Adenovirus, parainfluenza virus and respiratory syncytial virus antibodies in the sera of Jamaicans.

Authors:  R Jennings
Journal:  J Hyg (Lond)       Date:  1972-09

7.  Evaluation of multiplex type-specific real-time PCR assays using the LightCycler and joint biological agent identification and diagnostic system platforms for detection and quantitation of adult human respiratory adenoviruses.

Authors:  David Metzgar; Carl Gibbins; N Ryan Hudson; Morris S Jones
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

8.  Neutralizing antibodies against 33 human adenoviruses in normal children in Rome.

Authors:  E D'Ambrosio; N Del Grosso; A Chicca; M Midulla
Journal:  J Hyg (Lond)       Date:  1982-08

9.  Fluorescent antibody responses to adenoviruses in humans.

Authors:  J P Ariyawansa; J O Tobin
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.